FAS and neoplasm: In parallel to FasL expression, cancer cells often display resistance to Fas-mediated apoptosis and therefore ‘the Fas counterattack’ concept was introduced to describe the modulation of the Fas–FasL system by tumour cells to favour their immune privilege (O'Connell et al, 1999).